Connect with us

Health

There’s No Need For Surgery To Reverse Enlarged Heart, Don Says

Published

on

While it usually takes an open heart surgery to reverse heart enlargement, Professor Ben Amodu has said it really does not need surgery to reverse any enlarged heart.


He made this revelation on Friday while speaking to Journalist’s on the advantages of Traditional, Complementary and Alternative Medicine, TCAM, over modern medicine.


Speaking while conducting a tour of his African Alternative Medicine Hospital at Zone 6, Wise, Abuja, he said one outstanding comparative advantage of traditional medicine over complementary medicine is the absence of side effects with TCAM


He said: “Our own medications at Halamin Herbals and African Alternative Medicine Hospital, do not have any side effect whatsoever.


“It is currently estimated that globally, cardiovascular disease alone kills an average of 17.9 million people annually, and High Blood
Pressure, HBP, is one major issue that contributes to this.


“But all the synthetic medicines in use have various side effects, including medications for HBP. For instance, two major side effects blood pressure medicines causes is first, erectile dysfunction which makes men who are on it to be unable to properly meet with their partners. And secondly, it causes generalised body weakness that reduces their productivity and their capacity to do any form of work.


“But with the natural medicine, it alleviates all issues relating to general weakness of the body and clears it within the treatment period.”
He then explained further making a surprising revelation: “Also, synthetic medicines cannot treat hypertension or HBP properly because there’s a heart related issue where the hearts of suffers are enlarged to various levels – some slightly, others very pronounced.

But the good news here is that our products have the capacity to reverse the enlarged hearts back to normal.


“All the various veins, arteries and capillaries that cause the enlargement can be cleared of their impurities which affects the heart’s capacity to function well, but in the modern medicine, if you want to treat an enlarged heart, you have to carry out a complicated open heart surgery where you cut it open and clean it up for a person who most times is over 60 or 70 years old making very many of them to die on the operation table.”


He then emphasised that with his medication, the patients do not need to go under the knife because the medicines themselves will go in there and do the cleaning, thereby making it by far much safer and effective.

Continue Reading

Health

Experts call for pharma sector harmonisation

Published

on

Health sector experts have called for the harmonisation of pharmaceutical activities in Nigeria to eliminate duplication, enhance efficiency, and improve access to quality medicines and health products.


The call was made on Wednesday in Abuja during a high-level stakeholders’ engagement focused on aligning efforts under the Improving Access to Medicines through Policy and Technical Support (IMPACT) project.


Dr Tayo Hamzat, Supply Chain Management Officer at the World Health Organisation (WHO), said the engagement was timely, considering the number of ongoing but uncoordinated interventions in the sector.


“Harmonisation will lead to faster access to health products, lower costs, improved efficiency, and better regulatory oversight.


“It requires collaboration and a focus on strengthening national systems.”


He described Nigeria’s pharmaceutical system as “robust and huge” but hindered by weak coordination and fragmented management structures.


Dr Francis Ohanyido, Director-General of the West Africa Institute of Public Health, said such collaboration was “common sense” given limited development financing and the need to optimise resources.


“Market shaping is a critical tool.
“Harmonisation can help us identify clear gaps we need to fill, especially in preparation for the African Continental Free Trade Area (AfCFTA),” he said.


Dr Anthony Ayeke, Programme Manager for Health and Nutrition at the EU Delegation to Nigeria and ECOWAS, reaffirmed the EU’s commitment to supporting a resilient, locally driven pharmaceutical sector.


“Harmonisation can accelerate local production, reduce import dependency, and improve healthcare system resilience,” he noted.


He also recommended regulatory streamlining, value chain capacity building, innovation, and public-private partnerships.


Dr Abdu Mukhtar, National Coordinator of the Pharmaceutical Value Chain Transformation Committee (PVAC), commended ongoing efforts under the IMPACT project.


Represented by Dr Muhammad Balarabe, Technical Associate at PVAC, he emphasised the committee’s focus on catalysing local production and attracting sustainable investment.


“Let’s use this platform to strengthen partnerships and align interventions with the vision of affordable, high-quality healthcare for all Nigerians,” he said.


Dr Obi Adigwe, Director-General of the National Institute for Pharmaceutical Research and Development (NIPRD), said fragmented interventions and redundant regulations had long stunted growth in the sector.


Represented by Prof. Philip Builders, Professor of Pharmaceutics at NIPRD he said: “Equitable access to quality medicine is the foundation of universal healthcare.


“The lack of access is not just a health issue; it’s about equity, national security, and economic survival.


“Harmonisation isn’t just about avoiding duplication; it’s about aligning policy, investment, and technical frameworks to achieve measurable results.”


He urged stakeholders to develop practical short, medium, and long-term strategies to make Nigeria’s pharmaceutical sector self-reliant, globally competitive, and able to meet national healthcare demands.


The meeting brought together key government agencies, development partners, and private sector actors, each reaffirming a shared commitment to a unified, efficient pharmaceutical ecosystem in Nigeria. 


NAN

Continue Reading

Trending

error

Enjoy this blog? Please spread the word :)